Browsing by Author Anekthananon T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2009Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: A prospective multicenter studySungkanuparph S.; Filler S.G.; Chetchotisakd P.; Pappas P.G.; Nolen T.L.; Manosuthi W.; Anekthananon T.; Morris M.I.; Supparatpinyo K.; Kopetskie H.; Kendrick A.S.; Johnson P.C.; Sobel J.D.; Larsen R.A.
2009Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitisManosuthi W.; Sungkanuparph S.; Anekthananon T.; Supparatpinyo K.; Nolen T.L.; Zimmer L.O.; Pappas P.G.; Larsen R.A.; Filler S.G.; Chetchotisakd P.
2008Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008Sungkanuparph S.; Anekthananon T.; Hiransuthikul N.; Bowonwatanuwong C.; Supparatpinyo K.; Mootsikapun P.; Chetchotisakd P.; Kiertiburanakul S.; Tansuphaswadikul S.; Buppanharun W.; Manosuthi W.; Techasathit W.; Ratanasuwan W.; Tantisiriwat W.; Suwanagool S.; Leechawengwongs M.; Ruxrungtham K.
1-Apr-2010Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patientsManosuthi W.; Chetchotisakd P.; Nolen T.; Wallace D.; Sungkanuparph S.; Anekthananon T.; Supparatpinyo K.; Pappas P.; Larsen R.; Filler S.; Andes D.
2009A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitisPappas P.G.; Chetchotisakd P.; Larsen R.A.; Manosuthi W.; Morris M.I.; Anekthananon T.; Sungkanuparph S.; Supparatpinyo K.; Nolen T.L.; Zimmer L.O.; Kendrick A.S.; Johnson P.; Sobel J.D.; Filler S.G.
2011Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsAnekthananon T.; Manosuthi W.; Chetchotisakd P.; Kiertiburanakul S.; Supparatpinyo K.; Ratanasuwan W.; Pappas P.G.; Filler S.G.; Kopetskie H.A.; Nolen T.L.; Kendrick A.S.; Larsen R.A.
5Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>Currier J.; Britto P.; Hoffman R.; Brummel S.; Masheto G.; Joao E.; Santos B.; Aurpibul L.; Losso M.; Pierre M.; Weinberg A.; Gnanashanmugam D.; Chakhtoura N.; Klingman K.; Browning R.; Coletti A.; Mofenson L.; Shapiro D.; Pilotto J.; Bullo M.; Ivalo S.; Ogwu A.; Kakhu T.; Asmelash A.; Omoz-Oarhe A.; Hofer C.; MacHado E.; Menezes J.; Sidi L.; Pinto J.; Ferreira F.; Duarte G.; Coutinho C.; Sperhacke R.; Costamilan S.; Fernandes L.; Mpreira L.; Kreitchmann R.; Coelho D.; De Melo M.; De Cassia Alves Lira R.; Aristhomene L.; Bonhomme J.; Infante R.; Rosas F.; Montalban E.; Rios J.; Chokephaibulkit J.; Anekthananon T.; Achalapong J.; Kantipong P.; Halue G.; Rasri W.; Yuthavisuthi P.; Techapornroong M.; Prommas S.; Layangool P.; Bowonwatanuwong C.; Chotivanich N.; Tongprasert F.; Sugandhavesa P.; Cajahuaringa V.; Weinman R.; Mattiucci S.; Kumar P.; Timpone J.; McMullen-Jackson C.; Buschur S.
2011Two-year safety and tolerability study of enfuvertide use in salvage therapy of Thai HIV-1 experienced casesPrasithsirikul W.; Hanvanich M.; Suwanagool S.; Ratanasuwan W.; Anekthananon T.; Techasathit W.; Supparatpinyo K.; Viphagool A.